Nervive, Inc. Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Industry:
Health Care, Medical, Wellness
Last Funding Type:
Grant
Estimated Revenue:
Less than $1M
Total Funding:
$3.6M
Investors Number:
3
Headquarters:
Akron, Ohio, United States
Technology:
NeuroTech
Founded Date:
2013-12-31
Employee Number:
1-10